BRIEF published on 04/30/2024 at 07:05, 1 year 10 months ago Branicks Group AG Reports Operationally Successful Financial Year for 2023 Despite Market Challenges Real Estate Sustainability Market Conditions Branicks Group AG Financial Results 2023
BRIEF published on 04/30/2024 at 07:05, 1 year 10 months ago Branicks Group AG annonce un exercice financier 2023 réussi sur le plan opérationnel malgré les défis du marché Immobilier Résultats Financiers 2023 Durabilité Branicks Group SA Les Conditions Du Marché
BRIEF published on 04/30/2024 at 07:05, 1 year 10 months ago FUCHS SE Reports Mixed Results in Q1 2024 Despite Challenges Financial Outlook 2024 FUCHS SE EBIT Growth Quarterly Financials LUBCON Acquisition
BRIEF published on 04/30/2024 at 07:05, 1 year 10 months ago FUCHS SE annonce des résultats mitigés au premier trimestre 2024 malgré les défis FUCHS SE Croissance De L'EBIT Rapports Financiers Trimestriels Acquisition De LUBCON Perspectives Financières 2024
BRIEF published on 04/30/2024 at 07:05, 1 year 10 months ago DocMorris AG Completes CHF 200 Million Convertible Bonds Offering Investor Relations Convertible Bonds Financial Strategy CHF 200 Million DocMorris AG
BRIEF published on 04/30/2024 at 07:05, 1 year 10 months ago DocMorris AG finalise une émission d'obligations convertibles de 200 millions de CHF Stratégie Financière Liens Convertibles Relations Avec Les Investisseurs DocMorris AG 200 Millions De Francs
BRIEF published on 04/30/2024 at 07:05, 1 year 10 months ago ALSO Holding Announces New CEO, Wolfgang Krainz Operational Efficiency Corporate Leadership Executive Appointment ICT Industry Company Growth Strategies
BRIEF published on 04/30/2024 at 07:05, 1 year 10 months ago ALSO Holding annonce la nomination d'un nouveau PDG, Wolfgang Krainz Efficacité Opérationnelle Nomination À La Direction Industrie Des TIC Direction D'entreprise Stratégies De Croissance De L'entreprise
BRIEF published on 04/30/2024 at 07:05, 1 year 10 months ago Newron Reports Success in Evenamide Schizophrenia Study Evenamide Schizophrenia Treatment Treatment-resistant Phase II/III Study Glutamatergic Inhibition
BRIEF published on 04/30/2024 at 07:05, 1 year 10 months ago Newron annonce le succès de son étude sur la schizophrénie Evenamide Evenamide Résistant Aux Traitements Traitement De La Schizophrénie Étude De Phase II/III Inhibition Glutamatergique
Published on 03/16/2026 at 21:30, 39 minutes ago Zomedica Announces Record Fourth Quarter Revenue of $10.5 Million and Full Year Revenue of $32.0 Million for 2025, Reflecting 17% Annual Growth; Achieves 68% Gross Margin and Maintains $53.3 Million in Liquidity
Published on 03/16/2026 at 21:00, 1 hour 9 minutes ago Amdocs Brings AI-Accelerated Application Modernization to Enterprises with NVIDIA
Published on 03/16/2026 at 19:55, 2 hours 14 minutes ago GGL Resources Corp. Updates the Status of its Earn-In Agreement on its Gold Point High-Grade Gold-Silver Project, Nevada
Published on 03/16/2026 at 18:12, 3 hours 57 minutes ago Sekur Private Data Signs Distribution Agreement In Africa
Published on 03/16/2026 at 14:00, 8 hours 9 minutes ago Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression
Published on 03/16/2026 at 21:35, 34 minutes ago WEKA Maximizes Token Output With Lower Cost Per Token on NVIDIA BlueField-4 STX
Published on 03/16/2026 at 21:35, 34 minutes ago WEKA Accelerates AI Factory Deployment Times From Months to Minutes with Turnkey NVIDIA AI Data Platform Solution
Published on 03/16/2026 at 21:30, 39 minutes ago Nebius teams with NVIDIA to build cloud for robotics and physical AI
Published on 03/16/2026 at 20:53, 1 hour 16 minutes ago EQS-Adhoc: EPH Group AG: Extension of Alexander Lühr’s Executive Board contract; appointment of an additional Executive Board member
Published on 03/16/2026 at 19:50, 2 hours 19 minutes ago EQS-Adhoc: Softing AG approves 10% cash capital increase excluding subscription rights
Published on 03/16/2026 at 18:00, 4 hours 9 minutes ago Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 18:00, 4 hours 9 minutes ago Déclaration des transactions sur actions propres réalisées du 09/03/2026 au 13/03/2026
Published on 03/16/2026 at 17:58, 4 hours 11 minutes ago Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:58, 4 hours 11 minutes ago Aéroports de Paris S.A - Trafic du mois de février 2026
Published on 03/16/2026 at 17:56, 4 hours 12 minutes ago Reporting on share buyback transactions carried out between March 9 and March 13, 2026
